Prelude Capital Management, LLC Motus Gi Holdings, Inc. Transaction History

Prelude Capital Management, LLC

$1.57 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2020 Aug 14, 2020	SELL	$12.18 - $29.0 $1.36 Million - $3.23 Million	-111,301 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$9.94 - $54.8 $695,780 - $3.84 Million	-69,998 Reduced 38.61%	111,301 $75,000
Q4 2019 Feb 14, 2020	BUY	$29.6 - $49.4 $29,244 - $48,807	988 Added 0.55%	181,299 $415,000
Q3 2019 Nov 14, 2019	BUY	$39.2 - $63.2 $3.26 Million - $5.26 Million	83,179 Added 85.64%	180,311 $357,000
Q2 2019 Aug 14, 2019	BUY	$60.4 - $84.2 $5.87 Million - $8.18 Million	97,132 New	97,132 $294,000

About Motus GI Holdings, Inc.

Ticker MOTS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 2,996,840
Description
Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.

More about MOTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.